|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 35/00 | |||
| A61P 37/06 | |||
| A61K 39/395 | |||
| A61K 39/00 | |||
| A61K 45/06 |
| (11) | Number of the document | 2709627 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12785624.3 |
| Date of filing the European patent application | 2012-05-03 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/036405 |
| Date | 2012-05-03 |
| (87) | Number | WO 2012/158362 |
| Date | 2012-11-22 |
| (30) | Number | Date | Country code |
| 201161486697 P | 2011-05-16 | US |
| (72) |
JOSEPH, Alexandra, US
RICHARDS, Susan, US
RUZEK, Melanie, US
GARMAN, Richard, US
|
| (73) |
Genzyme Corporation,
50 Binney Street, Cambridge, MA 02142,
US
|
| (54) | INDUCTION OF IMMUNE TOLERANCE BY USING METHOTREXATE |
| INDUCTION OF IMMUNE TOLERANCE BY USING METHOTREXATE |